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Abstract
Introduction:  Prostate  biopsy,  usually  performed  by  a  transrectal  approach,  is  executed  when
there is  a  suspicion  of  prostate  cancer.  Neuroendocrine  tumors  (NETs)  are  epithelial  neoplasms
with predominant  neuroendocrine  differentiation  and  only  19%  of  them  are  localized  in  the
rectum.
Case report:  The  authors  describe  a  73-year-old  man  without  a  signiﬁcant  past  medical  history
that underwent  a  prostate  biopsy  because  of  urinary  complaints  and  elevated  serum  levels
of prostate  speciﬁc  antigen.  The  histology  revealed  a  well-differentiated  NET  characterized
as a  low-grade  tumor  (G1).  A  total  colonoscopy  revealed  a  5  mm  sessile  rectal  polyp  and  in
the splenic  ﬂexure  a  sessile  lesion  with  central  ulceration  with  5  cm  with  histological  features
compatible  with  an  adenocarcinoma.
Conclusion:  This  is  the  ﬁrst  case  reported  in  the  literature  of  a  rectal  NET  diagnosed  by  tran-
srectal prostate  biopsy.  This  case  is  particularly  unique  because  the  diagnosis  of  the  NET  lead
to the  subsequent  timely  detection  of  a  colonic  adenocarcinoma.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier
España, S.L.U.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license
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Resumo
Introduc¸ão:  A  biópsia  prostática  transretal  é  realizada  na  suspeita  de  cancro  da  próstata.
Os tumores  neuroendócrinos  (TNE)  são  neoplasias  epiteliais  com  diferenciac¸ão  predominantePróstata/patologia neuroendócrina  e  em  19%  dos  casos  localizam-se  no  reto.
Abbreviations: NET, neuroendocrine tumor; PSA, prostate speciﬁc antigen; TNM, tumor node metastases.
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Caso:  Os  autores  descrevem  o  caso  de  um  homem,  73  anos  de  idade,  sem  antecedentes  médicos
prévios, que  por  elevac¸ão  dos  níveis  séricos  de  antigénio  especíﬁco  prostático  realizou  biópsia
prostática  transretal.  A  histologia  revelou  TNE  bem  diferenciado  de  baixo  grau  (G1).  Foi  real-
izada posteriormente  colonoscopia  total  onde  se  observou  pólipo  séssil  de  5  mm  no  reto  distal.
No ângulo  esplénico  observou-se  ainda  um  lesão  séssil  de  5  cm  com  ulcerac¸ão  central  cujas
biopsias  foram  compatíveis  com  o  diagnóstico  de  adenocarcinoma.
Conclusão:  Este  é  o  primeiro  caso  relatado  na  literatura  de  um  TNE  retal  diagnosticado  por  bióp-
sia prostática  transretal.  Este  caso  é  peculiar  dado  que  o  diagnóstico  do  TNE  do  reto  permitiu
a detec¸ão  de  um  adenocarcinoma  do  cólon  num  estadio  inicial.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier
España, S.L.U.  Este  é  um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure  1  Colonoscopic  view,  in  retroﬂexed  maneuver,
showing in  the  lower  rectum  a  polypoid,  yellowish,  well-
circumscribed  lesion,  measuring  5  mm  compatible  with  a  rectal
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a. Introduction
rostate  cancer  is  the  leading  cancer  site  in  males  after  lung
ancer,1 however  screening  the  general  population  remains
 controversial  issue,  since  improved  patient  outcomes  have
ot  been  demonstrated.2--3 Prostate  biopsy,  typically  per-
ormed  by  an  urologist,  is  a  minimally  invasive  procedure
n  which  tissue  samples  are  obtained  through  two  differ-
nt  anatomic  approaches:  transrectal  (the  most  common)
nd  transperineal.4 Patients  are  referred  to  prostate  biopsy
n  the  presence  of  abnormal  digital  rectal  exam  or  when
epeated  abnormal  prostate  speciﬁc  antigen  (PSA)  values
re  found.5
Neuroendocrine  tumors  (NETs)  are  epithelial  neoplasms
ith  predominant  neuroendocrine  differentiation.6 There
re  two  major  categories:  well  and  poorly  differentiated
astrointestinal  NETs.  NETs  of  the  digestive  system  are  rel-
tively  rare  and  19%  of  them  are  localized  in  the  rectum.11
espite  the  low  frequency  of  colorectal  NETs,  they  are
requently  associated  with  synchronous  or  metachronous
ther  tumors,  with  an  annual  incidence  reported  of
--15%.7,8
The  authors  describe  a  case  report  where  a  polypoid  rec-
um  NET  with  5  mm  of  major  diameter  was  diagnosed  by
rostate  transrectal  biopsy.  The  patient  was  submitted  to  a
otal  colonoscopy  that  revealed  not  only  the  rectal  lesion,
hat  was  removed  with  a  snare,  but  also  a  colonic  adenocar-
inoma  in  the  splenic  ﬂexure.  This  is  the  ﬁrst  case  reported
n  the  literature  of  a  rectal  NET  diagnosed  by  transrectal
rostate  biopsy.
. Case presentation
e  describe  the  case  of  a  73-year-old  man  that  com-
lained  of  nocturia  and  pollakiuria  and  had  high  PSA  level.
 transrectal  prostate  biopsy  was  performed  and  revealed  a
ell-differentiated  NET  characterized  as  a  low-grade  tumor
G1).Total  colonoscopy  showed,  in  the  distal  rectum,  a  poly-
oid,  yellowish,  well-circumscribed  lesion,  measuring  5  mm
Fig.  1)  removed  with  a  diathermic  snare.  Biopsies  were
aken  from  a  5-cm  ulcerated  lesion  observed  in  the  splenic
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exure  occupying  half  of  the  circumference  of  the  lumen
Fig.  2).
Histologically,  the  rectal  lesion  was  a  tumor  centered  in
ubmucosa  and  focally  in  the  mucosa  with  a trabecular  and
cinar  pattern  composed  by  small  and  monomorphic  cells
ith  round  and  hyperchromatic  nuclei  and  eosinophilic  cyto-
lasm  (Fig.  3a).  There  was  no  necrosis  or  lymphovascular
nvasion.  The  immunohistochemical  study  revealed  strong
nd  diffuse  staining  of  the  tumor  cells  for  synaptophysin
ithout  expression  of  chromogranin  A  (Fig.  3b  and  c).  Mitotic
ndex  was  less  than  1  mitosis  per  10  high-power  ﬁeld.  The
roliferative  index  by  Ki-67  was  less  than  1%.  With  these  his-
ological  and  immunohistochemical  features  the  diagnosis  of
 well-differentiated  of  low-grade  NET  was  made.
The  rectal  NET  was  completely  excised  with  a  diather-
ic  snare  without  complications  (Fig.  4).  Colonic  biopsies
rom  the  splenic  ﬂexure  lesion  showed  tubulovillous  ade-
oma  with  high-grade  dysplasia  and  foci  of  intramucosal
denocarcinoma  (Fig.  5).
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Figure  2  Colonic  adenocarcinoma  in  the  splenic  ﬂexure  with
an ulcerated  lesion  with  an  apple-core  appearance.
Figure  4  Colonoscopic  view  of  the  distal  rectum  after
polypectomy  of  the  rectal  NET.
Figure  3  Neuroendocrine  tumor.  Higher  magniﬁcation  showing  monomorphic  cells  containing  small,  round  nuclei  and  eosinophilic
cytoplasm (a:  H&E  200×).  In  the  immunohistochemical  study  the  tumor  cells  stained  for  synaptophysin  (b:  200×)  without  expression
of chromogranin  A  (c:  200×).
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tumors. Endocrinol Metab Clin N Am. 2011;40:1--18.igure  5  High-grade  dysplasia  and  foci  of  adenocarcinoma  in
he splenic  ﬂexure  (H&E  200×).
Thoracic,  abdominal  and  pelvic  computed  tomogra-
hy  was  performed  and  revealed  no  metastases  nor
ymphadenopathies.  Laparoscopic  left  hemicolectomy  was
uccessfully  performed  and  the  colonic  adenocarcinoma  was
taged  as  pT2N0M0.
. Discussion
rostate  cancer  is  the  second  most  frequent  cancer  in  men,
owever  screening  the  general  population  remains  a  con-
roversial  issue.1,2 Prostate  biopsy  is  an  invasive  procedure
ade  usually  through  transrectal  approach.3 We  describe
 patient  with  a  histological  diagnosis  of  NET  (G1)  after  a
rostate  biopsy.  The  diagnosis  was  conﬁrmed  performing  a
olonoscopy  that  revealed  in  the  distal  rectum  a  polypoid,
ellowish,  well-circumscribed  lesion  measuring  5  mm.  The
olonoscopy  performed  showed  an  ulcerated  lesion  in  the
plenic  ﬂexure  compatible  with  colonic  adenocarcinoma.
he  authors  describe  a  case  of  a  successful  diagnosis  of  a  rec-
um  NET  made  by  prostate  transrectal  biopsy  that  allowed
n  adenocarcinoma  colonic  diagnosis.
The  NET,  traditionally  referred  as  carcinoid,  often  has  the
appearance  of  well  circumscribed  round  lesions  in  the  sub-
mucosa  or  extending  to  the  muscular  layer.  As  shown  in
Fig.  3,  the  cut  surface  sometimes  has  a  yellowish  color
reﬂecting  the  high  lipid  content  of  these  lesions.  The
colonoscopy  performed  in  order  to  conﬁrm  the  histology
of  prostate  biopsy  revealed  another  neoplasm  --  a  colonic
adenocarcinoma  of  the  splenic  ﬂexure.  In  fact,  as  many
as  29%  of  gastrointestinal  carcinoids  exhibit  a  synchronous
or  metachronous  association  with  other  tumors,  usually
adenocarcinomas  of  the  colon.9
Our  patient  performed  thoracic  and  abdominopelvic
computed  tomography  that  excluded  the  presence  of
metastasis.  A  somatostatin  receptor  scintigraphy  was  also
performed  and  did  not  reveal  signiﬁcant  changes.  Imaging
by  positron-emission  tomography  is  not  routinely  recom-
mended  for  NETs  because  most  of  these  tumors  are  well
differentiated  and  have  a  low  metabolic  rate.10R.  Coelho  et  al.
According  to  the  TNM  staging  system  of  the  American
oint  Committee  on  Cancer/Union  for  International  Cancer
ontrol  the  tumor  was  classiﬁed  as  T2N0M0  (tumor  invades
uscularis  propria  without  regional  lymph  node  metastasis
nd  no  distant  metastasis).11 The  surgical  resection  is  the
rimary  treatment  modality  for  these  patients  with  local-
zed  colorectal  cancer.  A  laparoscopic  left  hemicolectomy
as  performed  without  complications.
Taking  into  consideration  this  case  we  think  that  patients
ould  be  submitted  to  screening  colonoscopy  or  ﬂexible  sig-
oscopy  before  performing  prostate  biopsy.  In  fact,  even  if
t  is  low,  the  risk  of  tumor  dissemination  during  the  prostate
iopsy  in  the  presence  of  rectal  tumors  must  be  considered.
. Conclusion
o  the  best  of  our  knowledge,  in  the  literature  this  is  the
rst  rectum  NET  diagnosed  by  prostate  transrectal  biopsy.
lthough  prostate  biopsy  is  a  relatively  frequent  procedure,
his  is  the  ﬁrst  case  of  a  NET  diagnosed  in  this  manner.  This
ase  is  particularly  unique  because  the  diagnosis  of  the  NET
ead  to  the  subsequent  timely  detection  of  a  colonic  adeno-
arcinoma.
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